Trial Profile
A Pilot Study of Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension
Status:
Not yet recruiting
Phase of Trial:
Phase 0
Latest Information Update: 12 Feb 2024
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 12 Feb 2024 New trial record